Organon & Co. (OGN) News
Filter OGN News Items
OGN News Results
|Loading, please wait...|
OGN News Highlights
- OGN's 30 day story count now stands at 9.
- Over the past 16 days, the trend for OGN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- DOW and MRK are the most mentioned tickers in articles about OGN.
Latest OGN News From Around the Web
Below are the latest news stories about Organon & Co that investors may wish to consider to help them evaluate OGN as an investment opportunity.
Organon & Co (NYSE: OGN ), which has recently spun-off from Merck & Co., Inc. (NYSE: MRK ), has inherited a global business across three segments, namely Womens Health, Legacy and Biosimilars brands, according to BofA Securities. The Organon Analyst: Jason Gerberry initiated coverage of Organon with a Buy rating and a price target of $43. The Organon Thesis: The company has a strong management team, with experience in working in the Big Pharma segment, Full story available on Benzinga.com
JERSEY CITY, N.J., September 01, 2021--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference on Monday, September 13, 2021 at 9:30 a.m. EDT.
JERSEY CITY, N.J., September 01, 2021--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT.
Warren Buffett still likes these high-yield plays — maybe you should too.
These are the healthcare stocks with the best value, fastest growth, and most momentum for September 2021.
Dow Jones Immediately, Shares Stoop As Markets Await Powell Feedback; Q2 Information Sinks House Depot, Lifts Walmart; Tesla Heads Decrease
The Dow industrials took a fast 350-point dive Tuesday, as earnings information, weak retail gross sales information and new rules in China helped drive early declines Earnings information lifted IBD 50 inventory Sea Ltd. Warren Buffets Berkshire Hathaway boosted Organon and Krogers. Retailers acquired prime billing on the Dow Jones at present, as Walmart and  The post Dow Jones Immediately, Shares Stoop As Markets Await Powell Feedback; Q2 Information Sinks House Depot, Lifts Walmart; Tesla Heads Decrease appeared first on Business News .
Warren Buffetts Berkshire Hathaway Inc said on Monday it has shed its holdings of drugmaker Biogen Inc and paint maker Axalta Coating Systems Ltd , while taking a new stake in another pharmaceutical company, Organon & Co. The changes were disclosed in a regulatory filing detailing Berkshires U.S.-listed holdings as of June 30. Berkshire has 
Firm reports new stake in a Merck & Co spinoff, Organon & Co.
The big shareholder groups in Organon & Co. ( NYSE:OGN ) have power over the company. Institutions will often hold...
JERSEY CITY, N.J., August 12, 2021--Organon (NYSE: OGN) (the "company"), today announced its results for the second quarter and year to date ended June 30, 2021 and affirmed its full year 2021 financial guidance.